Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biogenerics Get A Low Score From CBO, But Is BIO Actually The Loser?

Jun 30 2008

• By M. Nielsen Hobbs

Related Content

Rx, OTC, Supplement Concurrent Use Reported By Half Of Survey Respondents

Jan 22 2001

Roche Re-Models Around Disease Areas, Pulls Together R&D And Commercial

Feb 12 2007

Gardasil Clears FDA, But Dosing May Pose Administrative Challenges

Jun 12 2006

Antibiotic Assistance

Jun 01 2007

BIO’s Lucky Number 7? Follow-On Biologics Debate Offers Exclusivity Midpoint

Jun 04 2007

GSK Receives “Complete Response” Letter For Cervarix BLA

Dec 17 2007

FDA Losing Ground On Foreign Manufacturing Inspections, House Panel Says

Dec 03 2007

Follow-On Biologics Could Save Medicare $14 Bil. Over 10 Years – PCMA

Jan 08 2007

GlaxoSmithKline Submits Cervarix BLA

Mar 29 2007

FDA's Selective Response to the IoM Drug Safety Report

Mar 01 2007

Warfarin Dosing Issues Emerge In Early Results From Medco/Mayo Research

Nov 26 2007

New GSK Global Switch/Strategy Position Supports Firm’s OTC Commitment

May 26 2008

Introgen’s Advexin Doubles Survival In Some Head &amp; Neck Cancer Patients

May 28 2008

Lundbeck Places Significant Bet On Myriad Alzheimer’s Candidate Flurizan

May 22 2008

FDAAA Pays Off: Drug Safety Controls Bring Immediate Returns to Sponsors

May 01 2008

The REMS Era Begins: FDA Applies Soft Touch With New Drug Safety Tools

May 01 2008

Is FDA Less Confident In ANDAs? Stay On Efudex Generic May Set Precedent

May 19 2008

Oral Remodulin's Early PK Data Look Good

May 19 2008

CDER, ORA To Be Major Beneficiaries Of Speedier FDA Hiring Process

May 05 2008

FDA’s Price Tag For Foreign Facility Inspections Tops $225 Million

May 05 2008

FDA’s Office of Chief Counsel Is Growing Its Ranks As It Amends Its Act

May 05 2008

Sucampo/Takeda’s Amitiza First To Fill Zelnorm Void In IBS Market

May 05 2008

Introgen Advexin Data Strengthens Biomarker Case In Head And Neck Cancer Patients

Apr 14 2008

J&amp;J’s R&amp;D Spending To Ease As Firm Focuses On Taking Pipeline To Market

Apr 15 2008

House Bill Requires Standard Numerical Identifiers For Drug Tracking By 2010

Apr 21 2008

GSK’s Treximet Could Face Market Headaches

Apr 21 2008

Straight Talk from FDA: Wyeth R&D Head Reacts to Climate Change for NDA/BLA Reviews

Nov 01 2007

Pyramid Schemes and Pipeline Dreams: Adapting to a Tiered Regulatory System for New Drugs

Nov 01 2007

Generic Biologics Bill’s Key Battleground May Be Senate Health Committee

Feb 19 2007

Generic Simvastatin No Heartache For Crestor Or Vytorin

Jul 30 2007

Pfizer Launch Plans For Lyrica Fibromyalgia Approval Include Patient Groups

Jul 02 2007

Biosimilar “Interchangeability” Standard Is Double-Edged Sword For Generics

Jul 02 2007

FDA Takes “Fresh Look” At ORA Reorg, Eyes Outsourcing Some Agency Posts

Aug 27 2007

Living in a Bipolar World: Implications of the EPO Safety Debate (Part 1)

Jul 01 2007

The New World for New Drug Approvals: Evolution in Strategies for Getting FDA Drug Approvals

Nov 01 2007

Roche To Build On Pharma, Diagnostics Expertise For Personalized Medicine

Jun 26 2006

FDA Approves Generic Of GSK Flonase But Launch Halted By Restraining Order

Feb 27 2006

Waking Up To REMS: Sponsors Should Test Risk Management In Phase III

Jun 23 2008

People In Brief

Jun 23 2008

Medicare Part D Boosts Public Share Of Retail Drug Spending To 34 Percent

Jan 14 2008

U.K. May Turn To “Value-Based” Drug Pricing In Place Of Price Limits

Mar 31 2008

FDA Begins Review Of E-Pedigree Options Just As California Delays Its Plan

Mar 31 2008

Reinforcements At Last: CDER Hiring Process Well Underway

Jun 01 2008

Cymbalta for Fibromyalgia: The REMS That Wasn't

Jul 01 2008

Playing the Priority Review Market: The Rules for Buyers and Sellers

Jul 01 2008

FDA's Priorities for Priority Review Vouchers

Jul 01 2008

Cashing in on the Voucher Market: Two Small Cap Biotechs Bid for Attention

Jul 01 2008

Advisory Committee Vacancies Remain High As FDA Revs Up Search Efforts

Jun 02 2008

RFID’s Possible Interaction With Biologics Queried By Biogen, Pfizer

Jun 16 2008

E-Rx, Dialysis Bundling Are Likely Survivors Of Failed Medicare Doc Fix Bill

Jun 16 2008

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window